Relevium Creates Alliance to Develop an Exclusive Line of Nutraceuticals for Pets
September 28 2017 - 10:01AM
InvestorsHub NewsWire
Relevium Creates Alliance With Salavenia Nutrition and Biodevas
Laboratoires to Develop an Exclusive Line of Phyto and
Nutraceuticals for Pets
MONTREAL, QUEBEC--(Marketwired - Sept. 28, 2017)
-Relevium Technologies Inc. (TSX
VENTURE:RLV)(FRANKFURT:6BX)
(the "Company" or "Relevium") is pleased to
announce the launch of a joint cooperation with Salvenia Nutrition
and Biodevas Laboratoires to develop an exclusive brand
and product line of nutraceuticals and phytoceuticals targeted to
Pet Care owners on a direct to consumer basis. Product and market
development initiatives are expected to begin in October of this
year with the objective of a preliminary launch by Spring of 2018
as a wholly-owned subsidiary of Relevium.
Relevium has retained Salvenia Nutrition
("Salvenia"), a Montreal based pet and livestock
nutrition company, to lead the market research and the product line
formulation process, which will consist of nutraceutical and
phytoceutical based products. In addition to their long-standing
expertise, Salvenia Nutrition is also an exclusive North American
distributor of Biodevas Laboratoires, a leading manufacturer
of veterinary Phytoceutical products based in France. Such
exclusivity will be extended to Relevium's newly developed product
line for e-commerce for an initial 18-month period from the first
product launch date, which is expected by spring of 2018.
Salvenia Nutrition with the assistance of a local nutraceutical
formulation lab will develop new products in conjunction with the
existing products currently available from the Biodevas Laboratoires.
Further updates will be issued as they become available.
Aurelio Useche, CEO of Relevium Technologies stated, "Much like their owners,
pets can also suffer from nutritional deficiencies related to poor
dietary intake. Keeping pets healthy and stronger requires
nutritional supplements, a market that is estimated to be north of
16 billion in North America alone. We look forward to leveraging
the expertise of Salvenia and Biodevas Laboratoires to develop
a high quality product line to fill a real need in this
market."
About Relevium Technologies
Relevium is a TSXV listed company
focused on growth through the acquisition of businesses, products
and/or technologies with a focus on e-commerce in the growing
health and wellness sector. Relevium Technologies Inc. also holds
patented intellectual property for the use of static magnetic
fields for application on wearable devices.
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of
this release.
Cautionary Note Regarding Forward-Looking
Statements
This press release may contain forward-looking information within
the meaning of applicable securities legislation, which reflects
the Company's current expectations regarding future events.
Forward-looking information is based on a number of assumptions and
is subject to a number of risks and uncertainties, many of which
are beyond the Company's control that could cause actual results
and events to differ materially from those that are disclosed in or
implied by such forward-looking information. Readers should not
place undue reliance on forward- looking statements and
forward-looking information and are cautioned that reliance on such
information may not be appropriate for other purposes. The Company
does not undertake any obligation to update such forward-looking
information, whether as a result of new information, future events
or otherwise, except as expressly required by applicable law.
On Behalf of the Board of Directors
RELEVIUM TECHNOLOGIES INC.
Aurelio Useche
President and CEO
RELEVIUM TECHNOLOGIES INC.
Website: www.releviumtechnologies.com
Like us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Relevium Technologies (TSXV:RLV)
Historical Stock Chart
From Mar 2024 to Apr 2024
Relevium Technologies (TSXV:RLV)
Historical Stock Chart
From Apr 2023 to Apr 2024